Sign in

CIK 0000872589

  • Large accelerated filer

REGENERON PHARMACEUTICALS, INC.

Sign in to watch
Ticker
REGN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
NY
Entity type
Operating
EIN
133444607
Phone
+1 914-847-7000
Business address
777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
Former names
REGENERON PHARMACEUTICALS INC
  1. 4 Open-market sale EVP Research sold 3,540 shares at an average $629.34 ($2,227,851)
  2. 4 Open-market sale Director sold 100 shares at an average $607.14 ($60,714)
  3. 4 Open-market sale EVP Commercial sold 1,000 shares at $607.46 ($607,460)
  4. 4 Grant or award Director acquired 191 shares (grant or award)
  5. 4 Open-market sale EVP Commercial sold 1,000 shares at $625.00 ($625,000)
  6. 4 Grant or award Director acquired 191 shares (grant or award)
  7. 4 Grant or award Director acquired 191 shares (grant or award)
  8. 4 Grant or award Director acquired 191 shares (grant or award)
  9. 4 Grant or award Director acquired 191 shares (grant or award)
  10. 4 Open-market sale Director sold 100 shares at an average $624.95 ($62,495)
  11. 4 Grant or award Director acquired 191 shares (grant or award)
  12. 4 Grant or award Director acquired 191 shares (grant or award)
  13. 4 Grant or award Director acquired 191 shares (grant or award)
  14. 4 Shares withheld for taxes President and Chief Scientific gave up 310,097 shares (to pay taxes)
  15. 4 Other disposition Director disposed of 126 shares (code I)
  16. 4 Shares withheld for taxes SVP Controller gave up 270 shares (to pay taxes)
  17. 4 Shares withheld for taxes EVP Research gave up 697 shares (to pay taxes)
  18. 4 Shares withheld for taxes EVP Research and Development gave up 753 shares (to pay taxes)
  19. 4 Shares withheld for taxes EVP General Counsel and Secret gave up 697 shares (to pay taxes)
  20. 4 Open-market sale EVP Commercial sold 344 shares at $653.12 ($224,673)

Page 18 of 77 · 1,533 filings